Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECISION-Knee: Triamcinolone Injections for Knee Osteoarthritis
NCT07544576Phase 4Enrolling by invitation
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone acetonide in osteoarthritis (OA). Started Dec 2025; status: enrolling by invitation.
02
Drugs
triamcinolone acetonide
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07544576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07544576.